OLDSMAR, Fla., Oct. 1, 2009 (GLOBE NEWSWIRE) -- Cryo-Cell International, Inc. (OTCBB:CCEL) (“Company”), one of the largest and most established leaders in stem cell innovation today announced that it has signed an exclusive distribution agreement with its Chinese partner, S-Evans Biosciences, Inc. (SEB), a privately-held stem cell and genomics technology company for the distribution of C’elle menstrual stem cell technology in Thailand. The agreement will allow SEB to market and sell proprietary C’elle menstrual stem cell service exclusively throughout Thailand. C’elle specimens collected from clients in Thailand will be shipped to SEB’s laboratory in Hangzhou, China for processing and storage. The distribution agreement is anticipated to provide Cryo-Cell with future royalties from the processing and annual storage of C’elle service sold in Thailand, in addition to royalties expected from the previously announced exclusive license agreement established with SEB for C’elle in mainland China. The Thailand agreement provides SEB with the option to obtain a license for proprietary C’elle technology should they decide to establish a future laboratory operation in the country.
